Laura Bessen
Directeur/Membre du Conseil chez C4 THERAPEUTICS, INC.
Fortune : - $ au 31/05/2024
Profil
Laura Bessen is an Independent Director at C4 Therapeutics, Inc. and Artiva Biotherapeutics, Inc. She previously worked as the Vice President & Head-US Medical at Bristol Myers Squibb Co. Dr. Bessen holds an undergraduate degree from the State University of New York at Binghamton and a doctorate degree from New York University School of Medicine.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
C4 THERAPEUTICS, INC.
-.--% | 20/06/2024 | 0 ( -.--% ) | - $ | 31/05/2024 |
Postes actifs de Laura Bessen
| Sociétés | Poste | Début |
|---|---|---|
| C4 THERAPEUTICS, INC. | Directeur/Membre du Conseil | 29/07/2022 |
Artiva Biotherapeutics, Inc.
 Artiva Biotherapeutics, Inc. BiotechnologyHealth Technology Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA. | Directeur/Membre du Conseil | 03/03/2022 |
Anciens postes connus de Laura Bessen
| Sociétés | Poste | Fin |
|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/01/2016 |
Formation de Laura Bessen
| New York University School of Medicine | Doctorate Degree |
| State University of New York at Binghamton | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| C4 THERAPEUTICS, INC. | Health Technology |
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| Entreprise privées | 1 |
|---|---|
Artiva Biotherapeutics, Inc.
Artiva Biotherapeutics, Inc. BiotechnologyHealth Technology Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA. | Health Technology |
